SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 124,800
-200 (-0.16%)
Jan 9, 2026, 10:10 AM KST
7.31% (1Y)
| Market Cap | 9.77T |
| Revenue (ttm) | 675.41B |
| Net Income (ttm) | 320.47B |
| Shares Out | 78.31M |
| EPS (ttm) | 4,092.19 |
| PE Ratio | 30.50 |
| Forward PE | 39.39 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 45,755 |
| Average Volume | 173,245 |
| Open | 125,900 |
| Previous Close | 124,800 |
| Day's Range | 124,500 - 127,300 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.83 |
| RSI | 42.08 |
| Earnings Date | Feb 4, 2026 |